S01. AOCC Education Workshop: Tips from an expert
Room 3, December 16 (Wed), 09:00-10:30
more
09:00-09:20 |
Diagnosis of IBD: Clinical perspective Ida Hilmi, University of Malaya, Malaysia |
|
09:20-09:40 |
Differential diagnosis of IBD: A pathologist's advice Jihun Kim, University of Ulsan, Korea |
|
09:40-10:00 |
Role of conventional medications in the biologic era Yue Li, Peking Union Medical College Hospital, China |
|
10:00-10:20 |
Optimization of IBD therapeutics by evolving treatment goals Miguel Regueiro, Cleveland Clinic, USA |
|
10:20-10:30 |
Discussion |
SS01. Treat to Target – A key piece of the IBD treatment puzzle
Room 1, December 16 (Wed), 09:30-10:30
more
09:30-10:00 |
Targeting success – A tight disease control strategy in IBD Edward V. Loftus, Jr., Mayo Clinic, USA |
|
10:00-10:30 |
Evidence to support optimal IBD management in clinical practice Taku Kobayashi, Kitasato University Kitasato Institute Hospital, Japan |
SS02. Personalized CD management: Are we there yet?
Room 2, December 16 (Wed), 09:30-10:30
more
09:30-10:00 |
Treat-to-target as a management strategy in CD Siew Chien Ng, The Chinese University of Hong Kong, Hong Kong |
|
10:00-10:30 |
How to choose and sequence CD treatment in bio-naïve patients? Won Moon, Kosin University, Korea |
S02. Current issues of IBD in Asia
Room 1, December 16 (Wed), 10:50-12:20
more
10:50-11:10 |
Epidemiological trends of IBD: What is new? Siew Chien Ng, The Chinese University of Hong Kong, Hong Kong |
|
11:10-11:30 |
Diagnostic challenges of IBD: How to differentiate IBD mimics? Zhihua Ran, Shanghai Jiao-Tong University School of Medicine, China |
|
11:30-11:50 |
Smart use of thiopurine and anti-TNF: What should we know? Tadakazu Hisamatsu, Kyorin University, Japan |
|
11:50-12:05 |
Early course of newly diagnosed moderate-to-severe ulcerative colitis in Korea: A population-based inception cohort study (MOSAIK) Jin Young Yoon, Kyung Hee University, Korea |
|
12:05-12:20 |
Discussion |
S03. New frontiers in the pathogenesis of IBD
Room 2, December 16 (Wed), 10:50-12:20
more
10:50-11:10 |
Recent updates on genetics research and its clinical implications Dermot P.B. McGovern, Cedars-Sinai Medical Center, USA |
|
11:10-11:30 |
Crosstalk between microbiome and host immune system Mi-Na Kweon, University of Ulsan, Korea |
|
11:30-11:50 |
Mucosal immune response and novel therapeutic targets Jae Hee Cheon, Yonsei University, Korea |
|
11:50-12:10 |
Cellular and molecular mechanisms of intestinal fibrosis Ren Mao, The First Affiliated Hospital of Sun Yat-sen University, China |
|
12:10-12:20 |
Discussion |
S04. Up-to-date radiological imaging in IBD
Room 3, December 16 (Wed), 10:50-12:20
more
10:50-11:10 |
Update on the role of CT enterography Se Hyung Kim, Seoul National University, Korea |
|
11:10-11:30 |
Current status and future directions of MR Enterography Seong Ho Park, University of Ulsan, Korea |
|
11:30-11:50 |
Ultrasonography as an emerging tool for IBD Jiro Hata, Kawasaki Medical School, Japan |
|
11:50-12:05 |
Preoperative multiparameter magnetic resonance enterography for prediction of early anastomotic recurrence after primary ileocolic resection in patients with Crohn's disease Jinfang Du, The First Affiliated Hospital, Sun Yat-sen University, China |
|
12:05-12:20 |
Is mixed use of MR enterography and CT enterography adequate for routine periodic follow-up for bowel inflammation in patients with Crohn's disease? Jiyeon Ha, Asan Medical Center, Korea |
SS03. Therapeutic strategies in IBD: Sequencing in advanced therapies
Room 1, December 16 (Wed), 12:20-13:20
more
12:20-12:50 |
Why sequencing could matter? Katsuyoshi Matsuoka, Toho University Sakura Medical Center, Japan |
|
12:50-13:20 |
Looking to the evidence of advanced therapy in IBD: What are the implications for sequencing therapies? Brian L Bressler, University of British Columbia, Canada |
SS04. Past, present and future of infliximab
Room 3, December 16 (Wed), 12:20-13:20
more
12:20-12:50 |
Treatment optimization with therapeutic drug monitoring Geom Seog Seo, Wonkwang University, Korea |
|
12:50-13:20 |
Future of infliximab: Subcutaneous formulation Byong Duk Ye, University of Ulsan, Korea |
S05. Microbiome in IBD: Friends or foes?
Room 1, December 16 (Wed), 13:40-15:10
more
13:40-14:00 |
Good bugs and bad bugs in colitis and colitis-associated cancer Christian Jobin, University of Florida, USA |
|
14:00-14:20 |
Viruses and fungi in the pathogenic and therapeutic perspectives Takayuki Imai, Shiga University of Medical Science, Japan |
|
14:20-14:40 |
FMT: Where are we now and where are we going? Young-Seok Cho, The Catholic University of Korea, Korea |
|
14:40-15:00 |
The future of microbiome engineering for IBD treatment Harry Sokol, Saint-Antoine Hospital, France |
|
15:00-15:10 |
Discussion |
S06. Recent advances in diagnosis and monitoring of IBD
Room 2, December 16 (Wed), 13:40-15:10
more
13:40-14:00 |
Optimal diagnosis in IBD: What will it change? Silvio Danese, Humanitas Research Hospital, Italy |
|
14:00-14:20 |
Emerging roles of biomarkers in IBD Shiro Nakamura, 2nd Department of Internal Medicine, Osaka Medical College, Japan |
|
14:20-14:40 |
Therapeutic drug monitoring: How, when, and for whom? Jia-Feng Wu, National Taiwan University Hospital, Taiwan |
|
14:40-14:55 |
Pharmacokinetics and immune mechanisms in patients receiving dose-optimization for loss-of-response to vedolizumab Bella Ungar, Chaim Sheba Medical Center, Israel |
|
14:55-15:10 |
Degree of creeping fat assessed by CT enterography is associated with intestinal fibrotic stricture in patients with Crohn's disease: A potentially novel mesenteric fat creeping index Xuehua Li, The First Affiliated Hospital of Sun Yat-Sen University, China |
S07. Looking into the operating room of IBD surgeons
Room 3, December 16 (Wed), 13:40-15:10
more
13:40-14:00 |
Evolving role of IBD surgery Willem A. Bemelman, Amsterdam University Medical Centers, Netherlands |
|
14:00-14:20 |
Total proctocolectomy in UC: Tips for laparoscopic surgery Seung-Bum Ryoo, Seoul National University, Korea |
|
14:20-14:40 |
Perianal Crohn’s disease: Surgical options to save anus Keisuke Hata, Nihonbashi-Muromachi Mitsui Tower Midtown Clinic, Japan |
|
14:40-15:00 |
Experiences of IBD Surgery in the era of biologics Kil Yeon Lee, Kyung Hee University, Korea |
|
15:00-15:10 |
Discussion |
S08. ECCO-AOCC Forum 2020
Room 1, December 16 (Wed), 15:30-17:00
more
15:30-15:45 |
Part 1. Small bowel CD Identification of stricture characteristic using cross sectional images: Inflammatory vs fibrotic Se Hyung Kim, Seoul National University, Korea |
|
15:45-16:00 |
Part 1. Small bowel CD Nonsurgical therapies: Drugs and balloon Sang-Bum Kang, The Catholic University of Korea, Korea |
|
16:00-16:15 |
Part 1. Small bowel CD Surgical treatment: optimal timing, preparation, and technique Willem A. Bemelman, Amsterdam University Medical Centers, Netherlands |
|
16:15-16:30 |
Part 2. Acute severe UC Optimal strategies for drug therapy: Which one, when, and how? Hiroshi Nakase, Sapporo Medical University, Japan |
|
16:30-16:45 |
Part 2. Acute severe UC Review of outcome predictors: Prognosticators and available indices Silvio Danese, Humanitas Research Hospital, Italy |
|
16:45-17:00 |
Part 2. Acute severe UC State of the art for surgical treatment Kyu Joo Park, Seoul National University, Korea |
S09. Multidisciplinary approach in challenging cases
Room 2, December 16 (Wed), 15:30-17:00
more
Panel Seong Ho Park, University of Ulsan, Korea Yong Sik Yoon, University of Ulsan, Korea Yeoun Joo Lee, Pusan National University, Korea Su Young Kim, Yonsei University Wonju, Korea |
||
15:30-16:00 |
Surgeon’s perspective for complicated CD Yong Sik Yoon, University of Ulsan, Korea |
|
16:00-16:30 |
Growth in pediatric Crohn's disease Yeoun Joo Lee, Pusan National University, Korea |
|
16:30-17:00 |
Optimal management for colitis-associated rectal cancer Su Young Kim, Yonsei University Wonju, Korea |
SS05. Evolving therapeutic goals in ulcerative colitis: Important role of 5-ASA
Room 3, December 16 (Wed), 15:30-16:00
more
15:30-15:45 |
Evolving therapeutic goals in ulcerative colitis: Important role of 5-ASA Silvio Danese, Humanitas Research Hospital, Italy |
|
15:45-16:00 |
Patient' survey of PENTASA® Sachet 2g in Korea: In patient's perspective of adherence and compliance Won Moon, Kosin University, Korea |